About GQ Bio
GQ Bio is a company based in Hamburg (Germany) founded in 2012 was acquired by Pacira in February 2025.. The company has 2 employees as of December 31, 2022. GQ Bio offers products and services including Gene Therapy Vector Platform and Transformative Medicines. GQ Bio operates in a competitive market with competitors including Flexion Therapeutics, Formation Bio, Rocket Pharma, Eupraxia Pharmaceuticals and MRM Health, among others.
- Headquarter Hamburg, Germany
- Employees 2 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gq Bio Therapeutics Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GQ Bio
GQ Bio offers a comprehensive portfolio of products and services, including Gene Therapy Vector Platform and Transformative Medicines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables efficient delivery of large genes for chronic diseases.
Develops treatments for conditions like osteoarthritis.
Funding Insights of GQ Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GQ Bio
GQ Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Pacira. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Injectable non-opioid products for post-surgical pain control are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GQ Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GQ Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gq Bio Comparisons
Competitors of GQ Bio
GQ Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Formation Bio, Rocket Pharma, Eupraxia Pharmaceuticals and MRM Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
Gene-modified cell therapies for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Sustained-release drug delivery platform for osteoarthritis therapies is developed.
|
|
| domain | founded_year | HQ Location |
Developer of optimized consortia therapeutics targeting inflammatory, CNS, and metabolic diseases
|
|
| domain | founded_year | HQ Location |
Oligonucleotide therapies for neuromuscular diseases like Myotonic Dystrophy are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about GQ Bio
When was GQ Bio founded?
GQ Bio was founded in 2012.
Where is GQ Bio located?
GQ Bio is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
Who is the current CEO of GQ Bio?
Kilian Guse is the current CEO of GQ Bio.
How many employees does GQ Bio have?
As of Dec 31, 2022, the latest employee count at GQ Bio is 2.
What does GQ Bio do?
Developer of gene therapies for orthopedic treatment. It offers a gene therapy vector platform that develops transformative medicines which include GQ-501, GQ-401, and GQ-203 to treat chronic diseases such as osteoarthritis and intervertebral disc degeneration.
Who are the top competitors of GQ Bio?
GQ Bio's top competitors include Flexion Therapeutics, Formation Bio and Eupraxia Pharmaceuticals.
What products or services does GQ Bio offer?
GQ Bio offers Gene Therapy Vector Platform and Transformative Medicines.
Who are GQ Bio's investors?
GQ Bio has 1 investor. Key investors include Pacira.